News

2019

company

year

domain

Syros Announces Appointment of Mark Alles to Its Board of Directors

Syros Pharmaceuticals 12.20.2019

Johnson & Johnson Acquires TARIS Biomedical with Focus on Transforming the Treatment of Bladder Cancer

TARIS Biomedical 12.20.2019

Flagship Unveils Newest Pioneering Platform: Ring Therapeutics

Ring Therapeutics 12.19.2019

Cygnal Appoints Elaine Caughey as Chief Business Officer

12.19.2019

Rubius Therapeutics Appoints Anne Prener, M.D., Ph.D., to its Board of Directors

12.18.2019

GBT and Syros Partner to Discover, Develop and Commercialize Novel Therapies for Sickle Cell Disease and Beta Thalassemia

Syros Pharmaceuticals 12.18.2019

Flagship Pioneering Strengthens Leadership With Appointment of Paul Biondi as Executive Partner

12.16.2019

Seres Therapeutics Appoints Stephen Berenson as Chairman of its Board of Directors

12.16.2019

Kaleido Biosciences to Advance KB174 for Hepatic Encephalopathy Based on Positive Top-Line Results from a Clinical Study in Patients with Cirrhosis

12.12.2019

Flagship Pioneering Unveils Cellarity, the First Company to Discover Medicines Targeting Cell Behavior

12.10.2019

Loading